Etoposide (VP-16) in the treatment of lung cancer.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000401:mortality; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013997:Time Factors
D005047:Etoposide; D011034:Podophyllotoxin